BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Viswanadh MK, Agrawal N, Azad S, Jha A, Poddar S, Mahto SK, Muthu MS. Novel redox-sensitive thiolated TPGS based nanoparticles for EGFR targeted lung cancer therapy. Int J Pharm 2021;602:120652. [PMID: 33915187 DOI: 10.1016/j.ijpharm.2021.120652] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 10.0] [Reference Citation Analysis]
Number Citing Articles
1 Dinakar YH, Karole A, Parvez S, Jain V, Mudavath SL. Organ-restricted delivery through stimuli-responsive nanocarriers for lung cancer therapy. Life Sciences 2022;310:121133. [DOI: 10.1016/j.lfs.2022.121133] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Bhattacharya S, Sharma S, Prajapati BG. Development of D-α-Tocopherol polyethylene glycol 1000 succinate fabricated nanostructural lipid carrier of sorafenib tosylate for metastatic colorectal targeting application: Stability, physical characterization, cytotoxicity, and apoptotic studies against SW48 cells PTEN. Front Oncol 2022;12. [DOI: 10.3389/fonc.2022.990841] [Reference Citation Analysis]
3 Rout SK, Priya V, Vikas, Mehata AK, Muthu MS. Abciximab coated albumin nanoparticles of rutin for improved and targeted antithrombotic effect. Journal of Drug Delivery Science and Technology 2022;76:103785. [DOI: 10.1016/j.jddst.2022.103785] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Vikas, Mehata AK, Suseela MNL, Behera C, Kumari P, Mahto SK, Muthu MS. Chitosan-alginate nanoparticles of cabazitaxel: Design, dual-receptor targeting and efficacy in lung cancer model. Int J Biol Macromol 2022;221:874-90. [PMID: 36089091 DOI: 10.1016/j.ijbiomac.2022.09.053] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Musarurwa H, Tavengwa NT. Cellulose composites tethered with smartness and their application during wastewater remediation. Reactive and Functional Polymers 2022;178:105332. [DOI: 10.1016/j.reactfunctpolym.2022.105332] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Priya V, Vikas, Mehata AK, Jain D, Singh SK, Muthu MS. Efficient delivery of abciximab using mesoporous silica nanoparticles: In-vitro assessment for targeted and improved antithrombotic activity. Colloids Surf B Biointerfaces 2022;218:112697. [PMID: 35917688 DOI: 10.1016/j.colsurfb.2022.112697] [Reference Citation Analysis]
7 Ding H, Tan P, Fu S, Tian X, Zhang H, Ma X, Gu Z, Luo K. Preparation and application of pH-responsive drug delivery systems. J Control Release 2022:S0168-3659(22)00327-3. [PMID: 35660634 DOI: 10.1016/j.jconrel.2022.05.056] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
8 Singh M, Rana NK, Muthu MS, Jha A, Basu Baul TS, Koch B. Enhanced in vitro therapeutic efficacy of triphenyltin (IV) loaded vitamin E TPGS against breast cancer therapy. Materials Today Communications 2022;31:103256. [DOI: 10.1016/j.mtcomm.2022.103256] [Reference Citation Analysis]
9 Sun C, Ma S, Chen Y, Kim NH, Kailas S, Wang Y, Gu W, Chen Y, Tuason JPW, Bhan C, Manem N, Huang Y, Cheng C, Zhou Z, Zhou Q, Zhu Y. Diagnostic Value, Prognostic Value, and Immune Infiltration of LOX Family Members in Liver Cancer: Bioinformatic Analysis. Front Oncol 2022;12:843880. [DOI: 10.3389/fonc.2022.843880] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
10 Sun Y, Huang Y, Qi T, Jin Q, Jia C, Zhao J, Feng S, Liang L. Wet-Etched Microchamber Array Digital PCR Chip for SARS-CoV-2 Virus and Ultra-Early Stage Lung Cancer Quantitative Detection. ACS Omega 2022;7:1819-26. [PMID: 35036821 DOI: 10.1021/acsomega.1c05082] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
11 Sarker SD, Nahar L. Characterization of nanoparticles. Advances in Nanotechnology-Based Drug Delivery Systems 2022. [DOI: 10.1016/b978-0-323-88450-1.00011-9] [Reference Citation Analysis]
12 Zhong T, Liu X, Li H, Zhang J. Co-delivery of sorafenib and crizotinib encapsulated with polymeric nanoparticles for the treatment of in vivo lung cancer animal model. Drug Deliv 2021;28:2108-18. [PMID: 34607478 DOI: 10.1080/10717544.2021.1979129] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]